| Identification | Back Directory | [Name]
Dolutegravir Impurity 8 | [CAS]
2244161-72-4 | [Synonyms]
2,6-Di fluoro Dolutegravir
2,6 Difluoro dolutegravir sodium salt
Dolutegravir 2,6-Difluoro Analog (Dolutegravir 4-Desfluoro 6-Fluoro Impurity)
4-Desfluoro-6-fluoro DolutegravirQ: What is
4-Desfluoro-6-fluoro Dolutegravir Q: What is the CAS Number of
4-Desfluoro-6-fluoro Dolutegravir
(4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,6-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)- | [Molecular Formula]
C20H19F2N3O5 | [MOL File]
2244161-72-4.mol | [Molecular Weight]
419.38 |
| Hazard Information | Back Directory | [Uses]
4-Desfluoro-6-fluoro Dolutegravir is impurity C of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. |
|
|